Stock Taper
EXCHANGE TRADED FUND

IHE

iShares U.S. Pharmaceuticals ETF
$100.09 ▲ 1.24%
+$1.23 TODAY

FUND FACTS

Manager IShares
Assets $1.53B
Expense ratio 0.37%
Inception May 1, 2006
Asset class Equity
Holdings 53
Volume 342.36K
Avg volume 237.38K

ABOUT THIS FUND

The iShares U.S. Pharmaceuticals ETF is designed to replicate the investment performance of a benchmark index. This index consists solely of equity securities from pharmaceutical companies operating within the United States.

PRICE

$100.09 ▲ UP 1.24% (+$1.23)
$98.50$99.00$99.50$1009:31 AM10:36 AM11:40 AM12:45 PM1:50 PM2:54 PM3:59 PM100.09

HOLDINGS

TOP 20 OF 53 · 90.77% OF THE FUND
RANK STOCK WEIGHT SHARES VALUE
01 LLY Eli Lilly and Company 24.00% 314.09K $363.55M
02 JNJ Johnson & Johnson 22.24% 1.32M $336.84M
03 PFE Pfizer Inc. 4.62% 2.54M $69.91M
04 VTRS Viatris Inc. 4.60% 3.97M $69.67M
05 ZTS Zoetis Inc. 4.54% 963.31K $68.71M
06 MRK Merck & Co., Inc. 4.49% 478.69K $67.95M
07 RPRX Royalty Pharma plc 4.34% 1.17M $65.78M
09 JAZZ Jazz Pharmaceuticals plc 3.43% 224.5K $51.95M
12 AXSM Axsome Therapeutics, Inc. 1.77% 153.98K $26.84M
14 DFTX Definium Therapeutics, Inc. 1.09% 464.69K $16.55M
15 INDV Indivior Pharmaceuticals Inc 0.97% 408.14K $14.65M
16 AMRX Amneal Pharmaceuticals, Inc. 0.86% 638.4K $12.96M
17 OGN Organon & Co. 0.82% 908.19K $12.48M
18 MANE Veradermics, Incorporated 0.78% 108.36K $11.81M
19 EWTX Edgewise Therapeutics, Inc. 0.74% 281.69K $11.27M
20 AMLX Amylyx Pharmaceuticals, Inc. 0.66% 355.93K $9.98M

SECTOR HOLDINGS

TECHNOLOGY IS 100.00% OF THE FUND
Healthcare 100.00%

BY REGION

UNITED STATES IS 96.15% OF THE FUND
United States 96.15%
Ireland 3.85%